Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis

IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain

(2011) John S. Tzartos et al.   AMERICAN JOURNAL OF PATHOLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis

(2011) Seung-Ki Kwok et al.   ARTHRITIS AND RHEUMATISM

Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse

(2011) H.H. Wang et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Simvastatin Inhibits IFN Regulatory Factor 4 Expression and Th17 Cell Differentiation in CD4+ T Cells Derived from Patients with Multiple Sclerosis

(2011) X. Zhang et al.   JOURNAL OF IMMUNOLOGY

Enhanced complement consumption in neuromyelitis optica and Behçet's disease patients

(2011) Erdem Tüzün et al.   JOURNAL OF NEUROIMMUNOLOGY

Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis

(2011) Ying Li et al.   JOURNAL OF NEUROIMMUNOLOGY

Neuromyelitis optica: An update

(2011) Sabrina Matà et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Impact of rituximab on relapse rate and disability in neuromyelitis optica

(2011) Gurdesh S Bedi et al.   Multiple Sclerosis Journal

Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

(2011) H. L. Pellkofer et al.   NEUROLOGY

No evidence of IL21 association with multiple sclerosis in a Swedish population

(2011) M. Lindén et al.   TISSUE ANTIGENS

Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands

(2011) Kwi Kang et al.   ARTHRITIS RESEARCH & THERAPY

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis

(2010) J. M. Fletcher et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo

(2009) Monika Bradl et al.   ANNALS OF NEUROLOGY

Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease

(2009) Giovanni Monteleone et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Regulatory effects of IFN-β on production of osteopontin and IL-17 by CD4+ T Cells in MS

(2009) Meiyue Chen et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production

(2009) Lin Xie et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

IL-21: An Executor of B Cell Fate

(2009) D. Konforte et al.   JOURNAL OF IMMUNOLOGY

Multiple sclerosis association study with theTENR-IL2-IL21region in a Spanish population

(2009) M. Fedetz et al.   TISSUE ANTIGENS

Interleukin-21 as a new therapeutic target for immune-mediated diseases

(2009) Giovanni Monteleone et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The role of IL-21 in regulating B-cell function in health and disease

(2008) Rachel Ettinger et al.   IMMUNOLOGICAL REVIEWS

Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody

(2008) H Doi et al.   Multiple Sclerosis Journal

Impaired Autoimmune T Helper 17 Cell Responses Following DNA Vaccination against Rat Experimental Autoimmune Encephalomyelitis

(2008) Åsa Andersson et al.   PLoS One

Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity

(2007) Rosanne Spolski et al.   Annual Review of Immunology